Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT) (effecT)
Sponsor: Biotronik SE & Co. KG
Terminated
Criterion according study protocol to end study prematurely was fulfilled.
Other terminated trials from Biotronik SE & Co. KG
Other Atrial Fibrillation trials with similar outcome
Listed as NCT00811382, this NA trial focuses on Atrial Fibrillation and Heart Failure (HF) and remains terminated or withdrawn. Sponsored by Biotronik SE & Co. KG, it has been updated 10 times since 2008, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
May 2017 — Jun 2018 [monthly]
Terminated NA
Status: Completed → Terminated
-
Jan 2017 — May 2017 [monthly]
Completed NA
First recorded
May 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik SE & Co. KG
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Antwerp, Belgium , Arnhem, Netherlands , Berlin, Germany , Bruges, Belgium , Chertsey, United Kingdom , Clermont-Ferrand, France , Dresden, Germany , Groningen, Netherlands , Leiden, Netherlands , Lille, France and 11 more locations